{
  "pmcid": "2772055",
  "sha256": "30c3b8ba39c10c9e24e87939a21a20e6f817b08d76f5217c33418f2e7f3016bc",
  "timestamp_utc": "2025-11-09T23:46:10.276433+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 14.168209150326796,
    "reading_ease": 17.057176470588274,
    "word_count": 225
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of the FLARE™ Imaging System for Sentinel Lymph Node Mapping in Breast Cancer Surgery"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Randomisation was achieved using a computer-generated sequence"
      },
      "Participants": {
        "score": 2,
        "evidence": "Eligibility criteria included adult women scheduled for SLN mapping."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants received 99m Tc-sulfur colloid lymphoscintigraphy and 12.5 µg of indocyanine green (ICG) in human serum albumin (HSA) as an NIR fluorescent tracer."
      },
      "Objective": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the number of SLNs identified by NIR fluorescence compared to 99m Tc-lymphoscintigraphy, assessed intraoperatively."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was achieved using a computer-generated sequence, with allocation concealment via sealed envelopes."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding was not feasible due to the intervention's nature."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "This randomised controlled trial was conducted at a single surgical center, involving 6 women undergoing sentinel lymph node (SLN) mapping for breast cancer."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "The analysis was conducted on a per-protocol basis."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "A total of 9 SLNs were identified by both 99m Tc-lymphoscintigraphy and NIR fluorescence, with discrepancies in two patients."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: [Trial registration number]."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: [Source of funding]."
      }
    },
    "total_score": 15,
    "max_score": 25
  }
}